Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine.
about
Direct demonstration of involvement of protein kinase Calpha in the Ca2+-induced platelet aggregationStructure and function of the platelet integrin alphaIIbbeta3New insights into the possible role of bacteriophages in host defense and diseaseIntegrin-Alpha IIb Identifies Murine Lymph Node Lymphatic Endothelial Cells Responsive to RANKLOrbofiban: an orally active GPIIb/IIIa platelet receptor antagonistLow molecular weight heparins and glycoprotein IIb/IIIa antagonistsFrequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirinAdditive effects between platelet concentrates and desmopressin in antagonizing the platelet glycoprotein IIb/IIIa inhibitor eptifibatidePharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplastyRGD-containing peptides inhibit fibrinogen binding to platelet alpha(IIb)beta3 by inducing an allosteric change in the amino-terminal portion of alpha(IIb)Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo.Releasing growth factors from activated human platelets after chitosan stimulation: a possible bio-material for platelet-rich plasma preparation.HPA-1 polymorphism of alphaIIbbeta3 modulates platelet adhesion onto immobilized fibrinogen in an in-vitro flow system.Platelet inhibition by low-dose aspirin but not by clopidogrel reduces the axon-reflex current-induced vasodilation in humans.The therapeutic use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.Use of glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST-elevation myocardial infarction.Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain.Actual Role of Platelet Glycoprotein IIb/IIIa Receptor Inhibitors as Adjunctive Pharmacological Therapy to Primary Angioplasty in Acute Myocardial Infarction: In the Light of Recent Randomized Trials and Observational Studies with Bivalirudin.Abciximab as an adjunctive therapy for patients undergoing percutaneous coronary interventions.PLA1A2 platelet polymorphism predicts mortality in prediabetic subjects of the population based KORA S4-CohortThe evolving role of platelet glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes.The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events.Emergence of low-molecular-weight heparins in cardiology.Analysis of number needed to treat and cost of platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary interventions and acute coronary syndromes.CD40L and Its Receptors in Atherothrombosis-An UpdateNewer antithrombotic strategies in the initial management of non-ST-segment elevation acute coronary syndromes.Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics.Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I--Pathophysiological and pharmacological features.Platelet adhesion receptors: novel targets for anti-thrombotic therapy.Stroke: antithrombin versus antiplatelet therapy.Novel approaches for the prevention of restenosis.Antiplatelet medications and their indications in preventing and treating coronary thrombosis.Glycoprotein IIb/IIIa receptor inhibitors in acute coronary syndromes: conquests and new challenges.Cell adhesion molecules--update.Dissociation of bimolecular αIIbβ3-fibrinogen complex under a constant tensile force.Integrin αIIb-mediated PI3K/Akt activation in platelets.The SCHOOL of nature: III. From mechanistic understanding to novel therapiesPlatelet adhesion under flow.The pharmacodynamics of parenteral glycoprotein IIb/IIIa inhibitors.The use of the glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary intervention.
P2860
Q24300892-327B2B7D-7642-45FE-A283-96B9F246FED1Q24536159-1951C43B-A168-4B3D-9FBC-31059AFA2358Q24804005-63CF6E87-BD4E-409C-8006-9FE6DC91A5EAQ27316867-A9177560-3F5F-4658-ABBC-2C4F4AFEE5D8Q28181764-223191FC-C799-4661-A73D-D72A58A7A73EQ28193196-19A1F5A2-F0D7-4F99-A9C6-0AB790D37206Q28212922-E8DBA884-A273-4C46-A642-E2DBEFC38469Q28218642-65CF577D-DF16-4A20-AB5A-20E402C84D0BQ28360267-86F55123-89FA-43A5-A765-A00739D7ABA7Q28577417-5ECCBB1B-43C8-4D35-86F7-8AC4BC9A6A3DQ30537304-077AD300-77D3-4A2C-A671-0B0154AAF84FQ30823262-AF580B9D-632E-4984-83A3-F0FDF31081F5Q33274590-418384B7-B385-438B-8E72-F66DBFA71E3BQ33318638-1F47360E-33BD-4412-A5BB-E73ABF938229Q33367036-DD90DE4E-F6C4-49D9-9C32-36B95DD511E6Q33369310-67600099-2127-40D8-84DA-317C33D79FEAQ33383170-0FD3A055-D5FB-4BD4-A26A-8AF8150A3E01Q33391341-26E2CE0E-F824-488A-A99F-1BC304A87FDFQ33393501-3A455230-4783-4D24-A1A4-8FBBBF67834CQ33617402-AD9EF932-44DE-4EBB-A2C2-FD2F9374E4CEQ33689211-ABE3BD45-3A52-4C0D-9C2E-032EBE9809D9Q33693990-9C40D644-F3ED-47FA-8D95-228048066FC4Q33803407-04FCA223-22C0-42D5-B983-AFD0F5C320ADQ33803432-DA782D26-0EC4-40DD-9B06-A854A0BBF5A0Q33814059-6C476E3F-4E24-4AD6-A337-BBEEFB33599CQ33838920-CCBCAACB-0CB2-4EA2-B098-659E057438ACQ33876187-4B5E88CA-4FCE-4A83-9CDD-4DFD3ABDCFFCQ33931454-CE177850-C1A8-4A43-BFAA-184857AF4B94Q33951293-1EE37609-B77B-4CCB-8A85-6A6138CF59E6Q34074721-459CC73C-A54D-4682-9F75-195BD5DCAD28Q34075160-FED5EB44-77B0-475C-A887-A540B04EAAB4Q34111901-74E960A2-6D5A-4248-B8A2-7AFA1637795EQ34126038-4867C0BD-1568-486C-8C29-3D5F6AC2F6E4Q34426127-73EC88B1-D225-4AC0-975D-2D4A476A357AQ34443614-1A5909C4-0C3A-4FC5-A822-CE2765931290Q34452068-8A71AD2D-095C-4444-BE60-A350E020BD12Q34619705-1486D00A-C4F9-4DC5-B1F9-C21D9B6935CEQ34673739-9E7BCED7-7B02-47CA-8617-F16BD1CA5669Q34675284-7FA5CFBA-4887-4F46-8A14-0B73D4EBCDECQ34675290-2CB96B7A-992C-422A-BA98-2B902D48B207
P2860
Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine.
@en
type
label
Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine.
@en
prefLabel
Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine.
@en
P1476
Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine.
@en
P2093
P304
P356
10.1056/NEJM199506083322306
P407
P50
P577
1995-06-01T00:00:00Z